TNYA:NASDAQ, Tenaya Therapeutics, Inc.

TNYA stock overview

Tenaya Therapeutics, Inc. (TNYA:NASDAQ) closed at $0.287 on November 20, 2026, down 3.99% on the day. The stock trades 80.4% below its 52-week high of $1.46 and 2.4% above its 52-week low of $0.280. Over the past year, it lost 76.5%. Tenaya Therapeutics, Inc. is part of the Health Care sector.

Key figures

Price
$0.287
Day change
-3.99%
Volume
4,341,574
Average volume
2,910,396
Market cap
65M+
52-week range
$0.280 – $1.46
50-day average
$0.480
200-day average
$0.682

Price action over the past year

In 252 trading sessions since November 20, 2025, TNYA closed higher on 109 days (43%). Its best day was March 5, 2026 (+40.96%) and its worst was December 12, 2025 (-37.50%). The stock moved 10% or more in a single session 14 times.

Recent signals

TNYA news

About Tenaya Therapeutics, Inc.

Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration, and precision medicine.

Similar stocks

Find more stocks like TNYA with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.